Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating ResultsGlobeNewsWire • 03/13/25
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025GlobeNewsWire • 03/10/25
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceGlobeNewsWire • 03/03/25
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastGlobeNewsWire • 02/19/25
Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024GlobeNewsWire • 11/19/24
Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/30/24
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational UpdateGlobeNewsWire • 09/27/24
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea DeviceGlobeNewsWire • 09/02/24
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating ResultsGlobeNewsWire • 08/06/24
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024GlobeNewsWire • 07/29/24
Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment BankGlobeNewsWire • 07/03/24
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDAGlobeNewsWire • 07/01/24